FDA To Convene Two-Day Meeting On DTC Advertising
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency requests public comment for Nov. 1-Nov. 2 meeting on risk/benefit information dissemination, presentation of brief summary for drugs, devices, vaccines and blood products.